Effect of Open-Label SGLT2 Inhibitor Treatment When Combined with Exenatide on Cardiovascular and Renal Outcomes in EXSCEL

Citation
Clegg LE, Penland RC, Boulton DW, et al. Diabetes 2019;68(Suppl 1):6-LB.